Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CXApp A | CXAI | Nov 27, 2024 | 1.59 | +4.61 |
CyberArk Software | CYBR | Nov 27, 2024 | 318.78 | -2.81 |
Cybin | CYBN | Nov 27, 2024 | 10.25 | -4.30 |
Cyclacel Pharmaceuticals | CYCC | Nov 27, 2024 | 0.34 | -2.54 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 27, 2024 | 6.75 | -2.74 |
Cyclerion Therapeutics | CYCN | Nov 27, 2024 | 2.16 | +58.82 |
Cyclo Therapeutics | CYTH | Nov 27, 2024 | 0.72 | +6.04 |
Cyngn | CYN | Nov 27, 2024 | 6.01 | -5.95 |
Cytek Biosciences | CTKB | Nov 27, 2024 | 6.50 | +1.40 |
Cytokinetics | CYTK | Nov 27, 2024 | 52.22 | +0.38 |
Cytomed Therapeutics | GDTC | Nov 27, 2024 | 2.31 | +3.59 |
CytomX Therapeutics | CTMX | Nov 27, 2024 | 1.02 | 0.00 |
Cytosorbents | CTSO | Nov 27, 2024 | 0.91 | +1.21 |
D-MARKET Electronic Services & Trading ADR | HEPS | Nov 27, 2024 | 2.89 | -1.70 |
D-Wave Quantum | QBTS | Nov 27, 2024 | 2.74 | +1.48 |
D.R. Horton | DHI | Nov 27, 2024 | 169.43 | +0.43 |
Dada Nexus ADR | DADA | Nov 27, 2024 | 1.43 | +6.72 |
Daily Journal | DJCO | Nov 27, 2024 | 565.51 | -1.24 |
Dakota Gold | DC | Nov 27, 2024 | 2.20 | +0.46 |
Daktronics | DAKT | Nov 27, 2024 | 15.40 | +2.53 |
DallasNews A | DALN | Nov 27, 2024 | 5.12 | -6.91 |
Damon | DMN | Nov 27, 2024 | 0.81 | 0.00 |
Dana | DAN | Nov 27, 2024 | 10.12 | +5.97 |
Danaher | DHR | Nov 27, 2024 | 238.83 | +0.95 |
Danaos | DAC | Nov 27, 2024 | 79.01 | -0.27 |
Danimer Scientific | DNMR | Nov 27, 2024 | 6.00 | +30.72 |
DAQO New Energy ADR | DQ | Nov 27, 2024 | 20.19 | +4.94 |
Darden Restaurants | DRI | Nov 27, 2024 | 174.98 | +0.65 |
Daré Bioscience | DARE | Nov 27, 2024 | 3.30 | +3.77 |
DarioHealth | DRIO | Nov 27, 2024 | 0.72 | +6.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.